One study, which examined the level of 5-hydroxymethylcytosine (5hmC), an intermediate epigenetic marker for DNA demethylation, at the FMR1 promoter region, reported differential findings in primary neurons of FXS patients and iPSCs derived from FXS patients [49]. The gene discussed is FMR1; the disease is fragile X syndrome.